Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Full-Size and Partially Truncated Cardiac Troponin Complexes in the Blood of Patients with Acute Myocardial Infarction.

Vylegzhanina AV, Kogan AE, Katrukha IA, Koshkina EV, Bereznikova AV, Filatov VL, Bloshchitsyna MN, Bogomolova AP, Katrukha AG.

Clin Chem. 2019 Mar 11. pii: clinchem.2018.301127. doi: 10.1373/clinchem.2018.301127. [Epub ahead of print]

PMID:
30858159
2.

Full-Size Cardiac Troponin I and Its Proteolytic Fragments in Blood of Patients with Acute Myocardial Infarction: Antibody Selection for Assay Development.

Katrukha IA, Kogan AE, Vylegzhanina AV, Kharitonov AV, Tamm NN, Filatov VL, Bereznikova AV, Koshkina EV, Katrukha AG.

Clin Chem. 2018 Jul;64(7):1104-1112. doi: 10.1373/clinchem.2017.286211. Epub 2018 Apr 9.

PMID:
29632125
3.

Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients.

Konev AA, Serebryanaya DV, Koshkina EV, Rozov FN, Filatov VL, Kozlovsky SV, Kara AN, Katrukha AG, Postnikov AB.

Clin Biochem. 2018 May;55:56-62. doi: 10.1016/j.clinbiochem.2018.03.004. Epub 2018 Mar 8.

4.

In Reply.

Katrukha IA, Kogan AE, Vylegzhanina AV, Koshkina EV, Bereznikova AV, Katrukha AG.

Clin Chem. 2017 Nov;63(11):1769-1770. doi: 10.1373/clinchem.2017.280800. Epub 2017 Sep 21. No abstract available.

5.

Thrombin-Mediated Degradation of Human Cardiac Troponin T.

Katrukha IA, Kogan AE, Vylegzhanina AV, Serebryakova MV, Koshkina EV, Bereznikova AV, Katrukha AG.

Clin Chem. 2017 Jun;63(6):1094-1100. doi: 10.1373/clinchem.2016.266635. Epub 2017 Apr 20.

6.

Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays.

Semenov AG, Tamm NN, Apple FS, Schulz KM, Love SA, Ler R, Feygina EE, Katrukha AG.

Clin Biochem. 2017 Mar;50(4-5):181-185. doi: 10.1016/j.clinbiochem.2016.11.003. Epub 2016 Nov 5.

7.

Anti-Cardiac Troponin Autoantibodies Are Specific to the Conformational Epitopes Formed by Cardiac Troponin I and Troponin T in the Ternary Troponin Complex.

Vylegzhanina AV, Kogan AE, Katrukha IA, Antipova OV, Kara AN, Bereznikova AV, Koshkina EV, Katrukha AG.

Clin Chem. 2017 Jan;63(1):343-350. doi: 10.1373/clinchem.2016.261602. Epub 2016 Nov 4.

8.

Analytical Issues with Natriuretic Peptides - has this been Overly Simplified?

Semenov AG, Katrukha AG.

EJIFCC. 2016 Aug 1;27(3):189-207. eCollection 2016 Aug.

9.

Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.

Semenov AG, Katrukha AG.

Clin Chem. 2016 Apr;62(4):617-22. doi: 10.1373/clinchem.2016.254524. Epub 2016 Feb 10.

10.

Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.

Kogan AE, Mukharyamova KS, Bereznikova AV, Filatov VL, Koshkina EV, Bloshchitsyna MN, Katrukha AG.

Blood Coagul Fibrinolysis. 2016 Jul;27(5):542-50. doi: 10.1097/MBC.0000000000000453.

11.

Characterization of endogenously circulating IGFBP-4 fragments-Novel biomarkers for cardiac risk assessment.

Konev AA, Smolyanova TI, Kharitonov AV, Serebryanaya DV, Kozlovsky SV, Kara AN, Feygina EE, Katrukha AG, Postnikov AB.

Clin Biochem. 2015 Aug;48(12):774-80. doi: 10.1016/j.clinbiochem.2015.05.010. Epub 2015 May 27.

12.

Clinical differences between total PAPP-A and measurements specific for the products of free PAPP-A activity in patients with stable cardiovascular disease.

Schulz O, Postnikov AB, Smolyanova TI, Katrukha AG, Schimke I, Jaffe AS.

Clin Biochem. 2014 Feb;47(3):177-83. doi: 10.1016/j.clinbiochem.2013.10.027. Epub 2013 Nov 5.

PMID:
24201068
13.

Oligomeric adiponectin forms and their complexes in the blood of healthy donors and patients with type 2 diabetes mellitus.

Kogan AE, Filatov VL, Kolosova OV, Katrukha IA, Mironova EV, Zhuravleva NS, Nagibin OA, Kara AN, Bereznikova AV, Katrukha AG.

J Immunoassay Immunochem. 2013;34(2):180-96. doi: 10.1080/15321819.2012.699494.

PMID:
23537302
14.

N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia.

Postnikov AB, Smolyanova TI, Kharitonov AV, Serebryanaya DV, Kozlovsky SV, Tryshina YA, Malanicev RV, Arutyunov AG, Murakami MM, Apple FS, Katrukha AG.

Clin Biochem. 2012 May;45(7-8):519-24. doi: 10.1016/j.clinbiochem.2011.12.030. Epub 2012 Jan 28.

PMID:
22306170
15.

Human pro-B-type natriuretic peptide is processed in the circulation in a rat model.

Semenov AG, Seferian KR, Tamm NN, Artem'eva MM, Postnikov AB, Bereznikova AV, Kara AN, Medvedeva NA, Katrukha AG.

Clin Chem. 2011 Jun;57(6):883-90. doi: 10.1373/clinchem.2010.161125. Epub 2011 Apr 7.

16.

Generation of recombinant antibodies and means for increasing their affinity.

Altshuler EP, Serebryanaya DV, Katrukha AG.

Biochemistry (Mosc). 2010 Dec;75(13):1584-605. Review.

17.

Development of a candidate secondary reference procedure (immunoassay based measurement procedure of higher metrological order) for cardiac troponin I: I. Antibody characterization and preliminary validation.

Noble JE, Bunk DM, Christenson RH, Cole KD, He HJ, Katrukha AG, Panteghini M, Porter RA, Schimmel H, Tate JR, Wang L; IFCC Working Group on Standardization of Troponin I (WG-TNI).

Clin Chem Lab Med. 2010 Nov;48(11):1603-10. doi: 10.1515/CCLM.2010.316.

PMID:
21062228
18.

Measurement of B-type natriuretic peptide by two assays utilizing antibodies with different epitope specificity.

Tamm NN, Semenov AG, Seferian KR, Bereznikova AV, Murakami MM, Apple FS, Koshkina EV, Krasnoselsky MI, Katrukha AG.

Clin Biochem. 2011 Feb;44(2-3):257-9. doi: 10.1016/j.clinbiochem.2010.09.030. Epub 2010 Oct 13.

PMID:
20950595
19.

Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases.

Semenov AG, Tamm NN, Seferian KR, Postnikov AB, Karpova NS, Serebryanaya DV, Koshkina EV, Krasnoselsky MI, Katrukha AG.

Clin Chem. 2010 Jul;56(7):1166-76. doi: 10.1373/clinchem.2010.143883. Epub 2010 May 20.

20.

[Diagnostic value of cardiac troponin T increase in critically ill patients].

Koshkina EV, Krasnosel'skiĭ MIa, Fedorovskiĭ NM, Goriacheva EV, Polupan AA, Aref'ev AA, Katrukha AG.

Anesteziol Reanimatol. 2009 Nov-Dec;(6):42-6. Russian.

PMID:
20101793
21.

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.

Semenov AG, Postnikov AB, Tamm NN, Seferian KR, Karpova NS, Bloshchitsyna MN, Koshkina EV, Krasnoselsky MI, Serebryanaya DV, Katrukha AG.

Clin Chem. 2009 Mar;55(3):489-98. doi: 10.1373/clinchem.2008.113373. Epub 2009 Jan 23.

22.
23.

Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood.

Tamm NN, Seferian KR, Semenov AG, Mukharyamova KS, Koshkina EV, Krasnoselsky MI, Postnikov AB, Serebryanaya DV, Apple FS, Murakami MM, Katrukha AG.

Clin Chem. 2008 Sep;54(9):1511-8. doi: 10.1373/clinchem.2007.100545. Epub 2008 Jul 7.

24.

Immunodetection of glycosylated NT-proBNP circulating in human blood.

Seferian KR, Tamm NN, Semenov AG, Tolstaya AA, Koshkina EV, Krasnoselsky MI, Postnikov AB, Serebryanaya DV, Apple FS, Murakami MM, Katrukha AG.

Clin Chem. 2008 May;54(5):866-73. doi: 10.1373/clinchem.2007.100040. Epub 2008 Mar 13.

25.

[Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].

Mazovets OL, Trifonov IR, Katrukha AG, Bereznikova AV, Medvedeva MV, Deev AD, Gratsianksiĭ NA.

Kardiologiia. 2008;48(1):24-9. Russian.

PMID:
18260992
26.

Comparison of soluble and placental transferrin receptors as standards for the determination of soluble transferrin receptor in humans.

Kogan AE, Filatov VL, Kara AN, Levina AA, Katrukha AG.

Int J Lab Hematol. 2007 Oct;29(5):335-40.

PMID:
17824913
27.

The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.

Seferian KR, Tamm NN, Semenov AG, Mukharyamova KS, Tolstaya AA, Koshkina EV, Kara AN, Krasnoselsky MI, Apple FS, Esakova TV, Filatov VL, Katrukha AG.

Clin Chem. 2007 May;53(5):866-73. Epub 2007 Mar 23.

28.

[Levels of fatty acid binding protein before and after direct current cardioversion of atrial fibrillation or flutter in patients without acute coronary syndrome].

Mazovets OL, Katrukha AG, Trifonov IR, Bereznikova AV, Deev AD, Gratsianskiĭ NA.

Kardiologiia. 2006;46(3):43-8. Russian.

PMID:
16710255
29.

[Prognostic significance of heart fatty acid binding protein in patients with non-ST elevation acute coronary syndrome: results of follow-up for twelve months].

Erlikh AD, Katrukha AG, Trifonov IR, Bereznikova AV, Gratsianskiĭ NA.

Kardiologiia. 2005;45(5):13-21. Russian.

PMID:
16007043
30.

[Diagnostic value of heart fatty-acid binding protein in early hospitalized patients with non ST elevation acute coronary syndrome].

Trifonov IR, Katrukha AG, Iavelov IS, Averkov OV, Gratsianskiĭ NA.

Kardiologiia. 2003;43(5):4-8. Russian.

PMID:
12891232
31.

[Heart fatty acid binding protein in patients with ST-elevation acute coronary syndrome hospitalized within 6 hours after onset of pain].

Trifonov IR, Katrukha AG, Deev AD, Iavelov IS, Averkov OV, Kuznetsov BV, Gratsianskiĭ NA.

Kardiologiia. 2002;42(6):18-23. Russian.

PMID:
12494125
32.

Troponin: structure, properties, and mechanism of functioning.

Filatov VL, Katrukha AG, Bulargina TV, Gusev NB.

Biochemistry (Mosc). 1999 Sep;64(9):969-85. Review.

33.
34.

Degradation of cardiac troponin I: implication for reliable immunodetection.

Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K, Lövgren T, Bulargina TV, Trifonov IR, Gratsiansky NA, Pulkki K, Voipio-Pulkki LM, Gusev NB.

Clin Chem. 1998 Dec;44(12):2433-40.

35.

Epitope mapping of anti-troponin I monoclonal antibodies.

Filatov VL, Katrukha AG, Bereznikova AV, Esakova TV, Bulargina TV, Kolosova OV, Severin ES, Gusev NB.

Biochem Mol Biol Int. 1998 Sep;45(6):1179-87.

PMID:
9762417
36.

Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex.

Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lövgren T, Severina ME, Pulkki K, Vuopio-Pulkki LM, Gusev NB.

Clin Chem. 1997 Aug;43(8 Pt 1):1379-85.

37.

Application of anti-E1 monoclonal antibodies to the study of the pyruvate dehydrogenase complex.

Stafejeva OA, Khailova LS, Katrukha AG, Bulargina TV.

Biochem Mol Biol Int. 1995 Sep;37(1):167-73.

PMID:
8653079
38.

A new method of human cardiac troponin I and troponin T purification.

Katrukha AG, Bereznikova AV, Esakova TV, Filatov VL, Bulargina TV, Gusev NB.

Biochem Mol Biol Int. 1995 May;36(1):195-202.

PMID:
7545051
39.

[Preparation of monoclonal antibodies to E1-component and their use for studying the pyruvate dehydrogenase complex].

Stafeeva OA, Khaĭlova LS, Katrukha AG, Bulargina TV.

Biokhimiia. 1995 Jan;60(1):124-30. Russian.

PMID:
7535107
40.

Production and characterization of a monoclonal antibody specific for the E1 component of the pyruvate dehydrogenase complex.

Stafejeva OA, Katrukha AG, Bulargina TV, Khailova LS.

Biochem Mol Biol Int. 1994 Aug;34(1):9-15.

PMID:
7849629
41.
42.

[Localization of antigenic sites for monoclonal antibodies against alpha-subunit of Go-protein from the bovine brain].

Katrukha AG, Bereznikova AV, Kochanova NA, Gareeva AB, Popov KM, Bulargina TV, Severin ES.

Biokhimiia. 1990 Jul;55(7):1222-8. Russian.

PMID:
1699609

Supplemental Content

Loading ...
Support Center